Legal & General Group
CNCE

Legal & General Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Legal & General Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,390
Closed -$17K – 3712
2021
Q1 		$17K Buy
3,390
+868
+34% +$7.01K ﹤0.01% 3198
2020
Q4 		$32K Hold
2,522
– – ﹤0.01% 2934
2020
Q3 		$25K Sell
2,522
-1,109
-31% -$10.9K ﹤0.01% 2917
2020
Q2 		$36K Buy
3,631
+332
+10% +$3.18K ﹤0.01% 2828
2020
Q1 		$29K Sell
3,299
-236
-7% -$2.33K ﹤0.01% 2780
2019
Q4 		$33K Hold
3,535
– – ﹤0.01% 3010
2019
Q3 		$21K Hold
3,535
– – ﹤0.01% 3122
2019
Q2 		$42K Hold
3,535
– – ﹤0.01% 2848
2019
Q1 		$43K Buy
3,535
+358
+11% +$5.28K ﹤0.01% 2764
2018
Q4 		$40K Hold
3,177
– – ﹤0.01% 2780
2018
Q3 		$47K Hold
3,177
– – ﹤0.01% 2801
2018
Q2 		$53K Buy
3,177
+5
+0.2% +$97 ﹤0.01% 2723
2018
Q1 		$73K Sell
3,172
-1,380
-30% -$30.7K ﹤0.01% 2588
2017
Q4 		$118K Sell
4,552
-862
-16% -$17.4K ﹤0.01% 2506
2017
Q3 		$79K Buy
5,414
+985
+22% +$14.3K ﹤0.01% 2756
2017
Q2 		$62K Hold
4,429
– – ﹤0.01% 2844
2017
Q1 		$74K Sell
4,429
-739
-14% -$8.86K ﹤0.01% 2714
2016
Q4 		$53K Buy
5,168
+3,033
+142% +$27.7K ﹤0.01% 2877
2016
Q3 		$21K Hold
2,135
– – ﹤0.01% 2808
2016
Q2 		$24K Hold
2,135
– – ﹤0.01% 2810
2016
Q1 		$29K Buy
+2,135
New +$30.7K ﹤0.01% 2595

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Legal & General Group's CNCE Position: Q2 2021 in Review

Legal & General Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 3,390 shares — an estimated $17K sold.

Legal & General Group first reported a position in CNCE in Q1 2016 and held it in 21 quarters. The position peaked at $118K in Q4 2017. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • Legal & General Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 3,390 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $17K.
  • Legal & General Group first reported a position in Concert Pharmaceuticals, Inc. in Q1 2016 and held it in 21 quarters.
  • Legal & General Group's Concert Pharmaceuticals, Inc. position peaked at $118K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.